NCT03843983View on ClinicalTrials.gov

Effect of Thermal Pulsation System (Lipiflow) Treatment for Ocular Surface Disease Due to Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

October 13, 2020

Study Completion Date

October 13, 2020

Conditions
Evaporative Dry Eye Disease
Interventions
DEVICE

Lipiflow® application

"Lipiflow® will be applicated in both lids of each eye during 12 minutes once. Firstly, a drop of anesthetic will be instilled in each eye. Then, while the participant stays with his eyes closed, a one-used applicator will be placed covering the subject's lid. The instrument applies heat and pressure in the lid during 12 minutes. Time frame: between 2 and 7 days after visit 1.~Then, there will be 3 follow-up visits in 3, 6 and 12 months after treatment."

Trial Locations (1)

47012

Instituto Universitario de Oftalmobiología Aplicada (IOBA), Valladolid

All Listed Sponsors
lead

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

OTHER

NCT03843983 - Effect of Thermal Pulsation System (Lipiflow) Treatment for Ocular Surface Disease Due to Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter